Article info

PDF
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

Authors

  1. Correspondence to Professor Ali Canbay, Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Magdeburg 39120, Germany; ali.canbay{at}med.ovgu.de
View Full Text

Citation

Bantel H, Canbay A
Loss of KRAS control as consequence of downregulated microRNA-622 in hepatocellular carcinoma and its potential therapeutic implication

Publication history

  • Received January 3, 2018
  • Revised January 4, 2018
  • Accepted January 8, 2018
  • First published January 20, 2018.
Online issue publication 
June 07, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.